Laboratories in the age of artificial intelligence: current dynamics and future developments

A scientific environment under pressure: why AI is becoming essential

Laboratories are operating in a context of continuous growth in analytical activity. The global testing services market—covering environmental, food, industrial, and specialized analyses—was valued at nearly USD 162 billion in 2024 and is expected to reach USD 264 billion by 2033, representing an average annual growth rate of approximately 5.6%. This momentum is also reflected in clinical laboratory services, which market is projected to reach nearly USD 467 billion by 2032 (CAGR ~7.0%).

At the same time, the proliferation of instruments and data sources is making it increasingly difficult to obtain a consolidated and reliable view of results. Teams are also facing a shortage of qualified personnel, illustrated in France by a 7% decline in the number of medical biologists since 2014. This strain is compounded by the implementation of stringent regulatory frameworks, such as the European IVDR Regulation (which came into force in 2022), introducing unprecedented requirements for traceability and documentation across all in vitro diagnostic devices.
In this context, artificial intelligence is emerging as a relevant response to several key challenges. It helps ensure operational continuity despite workforce constraints, enhances analytical quality, and enables more forward-looking operational management. While adoption varies across sectors and levels of digital maturity, the trend is structural: laboratories are gradually digitizing, and AI is becoming a natural component of this transformation.

This trend is illustrated by AlphaFold 3, developed by Google DeepMind. The tool enables the prediction of biomolecular interactions with unprecedented accuracy, significantly accelerating modeling phases in research.

Key AI use cases in laboratories: automation, reliability, and optimization

Automating repetitive tasks and reducing operational workload

Laboratories are seeking to reduce the time spent on repetitive, low-value, or error-prone tasks. Artificial intelligence enables the automation of:

• result interpretation;
• data classification and preprocessing;
• queue management and analytical prioritization;
• resource planning;
• preparation or adjustment of certain protocols.

These applications represent the first wave of AI integration. They are paving the way for systems capable of automatically orchestrating multiple analytical steps based on context, historical data, or real-time workload, opening the door to semi-autonomous analytical workflows.
In microbiology, the APAS Independence system uses AI to automatically sort culture plates and detect early anomalies. It reduces manual workload while improving standardization.

Improving reliability and strengthening quality control

AI also helps identify weak signals and deviations at an earlier stage. It facilitates:

• early detection of instrument drift;
• automated comparison with historical reference data;
• proactive alerting on anomalies;
• standardization of interpretation.

In diagnostics, a study published in The Lancet Digital Health shows that the Galen™ Prostate algorithm, used as a second reader, improves the detection of lesions missed during the initial review, thereby enhancing the overall sensitivity of clinical diagnosis.

Anticipating needs and optimizing resources

The predictive capabilities of artificial intelligence enable more stable and forward-looking operational management:

• forecasting sample volumes;
• optimizing reagent consumption;
• intelligent instrument scheduling;
• anticipating maintenance needs.

These applications improve overall laboratory management by enabling teams to anticipate bottlenecks, avoid operational disruptions, and better balance workloads across instruments and staff.

New performance-driven adoption criteria

Laboratories are now evaluating AI solutions based on criteria that include:

• interoperability with LIMS and existing systems;
• data security and sovereignty;
• measurable operational gains;
• model explainability, which has become essential to ensure team trust and meet regulatory expectations;
• ease of integration into existing workflows.

The central challenge is therefore the ability of AI tools to integrate into a coherent digital architecture, rather than operate as standalone modules.

Outlook: toward augmented laboratories and smarter organizations

Gradual and sustainable adoption

Feedback from the field highlights tangible results: AI enables faster analyses and reduces human error, ensuring better reproducibility of results, as noted by the Fédération des Biologistes de France (FBP). This allows teams to refocus on higher-value tasks, particularly the interpretation and validation of complex results. Machine learning also supports more agile management of workflows and data.
AI is becoming a lever for accelerating the upskilling of new teams and stabilizing processes in contexts of variable workload. It is being deployed across clinical laboratories, research, and quality control, with varying levels of maturity but a shared trajectory.
In bioproduction, the collaboration between Généthon and Thales illustrates this transition. Their digital twin makes it possible to model critical production steps, anticipate the impact of culture parameters, and virtually explore different operating conditions. This approach reduces the need for physical trials and helps optimize yields, making AI a structuring decision-support tool.

---

Learn more about how our team can support you in your projects related to AI in healthcare >

---

Toward new laboratory organizations

The integration of artificial intelligence is gradually transforming internal organization. Systems are no longer limited to automation: they learn from data, adapt to changing conditions, and support more fluid and resilient operations.

Process evolution:

• automatic adjustment of parameters based on sample type or workload;
• semi-autonomous protocols capable of adapting in real time;
• enhanced interactions between instruments, analytical platforms, and users.

Upskilling:

• development of digital skills, including data management, model validation, and cybersecurity;
• understanding predictive models to better manage analytical priorities;
• dual scientific and digital expertise, facilitating human–machine collaboration.

Enhanced quality:

• earlier detection of anomalies;
• automatic generation of alerts or corrective recommendations;
• improved rigor across the analytical chain through continuous algorithmic oversight.

These developments mark the transition from instrument-centered laboratories to data-driven laboratories.

Persistent barriers to adoption

Despite these benefits, several constraints remain:

• regulatory requirements (IVDR, ISO, GDPR);
• the need to store and protect data within sovereign environments;
• accountability in the event of algorithmic errors;
• limited understanding of models by users;
• lack of market clarity.

These challenges reinforce the need for structured support and education around AI.

New challenges and success factors

The transition toward augmented laboratories requires addressing several key challenges.

• Ensuring data quality and governance is essential and relies on standardized practices, robust and traceable data sources, and rigorous control of data flows to guarantee model stability.
• Maintaining the central role of human expertise remains critical, since human oversight is required to systematically validate AI-generated results, provide essential scientific contextualization, and identify situations where algorithms may fail.
• Finally, supporting organizational change requires continuous team training, adaptation of protocols to integrate AI, and clear definition of responsibilities and human–machine interactions.

Embedding AI within a strategic vision that aligns scientific objectives, quality, and operational performance will be a key success factor for laboratories.

Artificial intelligence is fundamentally transforming laboratories. It enhances efficiency, reliability, and predictive capabilities, while redefining skills and organizational models. Use cases are multiplying, benefits are becoming increasingly visible, and adoption criteria are evolving toward performance, compliance, and seamless integration into workflows.

Laboratories are entering a new phase of digital maturity, where AI becomes both an analytical and operational partner—amplifying team capabilities and reshaping operating models.

At Alcimed, we support industry stakeholders in understanding these use cases, structuring their AI strategy, and turning operational challenges into growth opportunities. How are you approaching AI integration in your laboratory? Don’t hesitate to contact our team to discuss further.

---

About the author, 

Alix, Consultant in Alcimed’s Innovation and Public Policy team in France